Stock Events

Stock Events

CRISPR Therapeutics (CRSP) Q2 2026 Earnings

4MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-2.4

-1.99

-1.58

-1.16

Details

Expected EPS

-1.218493

Actual EPS

-1.28

Surprise EPS

-0.06

Surprise Percent

+5.05%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.28 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.